Skip to content
Stop using now Drug recall · FDA · Published June 17, 2014

Hospira Recalls Marcaine Injections Due to Metal Particles

Hospira recalls 40,730 vials of Marcaine injection due to visible metal particles. Check lot numbers and expiration dates for affected units.

🇺🇸 FDA recall #D-0002-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling specific lots of Marcaine (bupivacaine HCl) injection because customers reported discolored solutions containing visible metal particles embedded in the glass vials. This Class I recall affects 40,730 single-dose vials distributed nationwide. The presence of particulate matter in an injectable drug poses a significant safety risk to patients. Read more at govinfonow.com/recall/46001-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-5.

Source Summary by GovInfoNow · govinfonow.com/recall/46001-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-5 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0002-2015

Cite this page

“Hospira Recalls Marcaine Injections Due to Metal Particles.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/46001-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-5. Based on FDA recall #D-0002-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0002-2015%22&limit=1).

The FDA announced on June 17, 2014, that Hospira Inc. voluntarily recalled Marcaine (bupivacaine HCl) injection vials due to the presence of particulate matter. The recall affects 40,730 units distributed nationwide.

How to tell if you have it

  • Brand: Hospira
  • Product: Marcaine Injection Vials
  • NDC: 0409-1560-29
  • Lot #: 33-545-DD
  • Expiration Date: 09/15
  • Quantity: 40,730 vials

The hazard

The recall addresses confirmed customer complaints of discolored solution containing visible metal particles embedded in the glass vial and suspended in the solution. This particulate matter poses a potential health risk to patients.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (July 24, 2026) and GE Healthcare Omnipaque 300 mg/mL Injection Recall (March 24, 2026).

How to tell if you have this one

Look for single-dose vials of Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg). Affected units have NDC 0409-1560-29, Lot # 33-545-DD, and an expiration date of 09/15.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Affected Vials

    Do not use any vials matching the specific lot number and expiration date identified in the recall.

  2. Check Inventory for Lot 33-545-DD

    Verify if you possess any of the 40,730 recalled vials by checking the NDC and lot number on the packaging.

  3. Contact Manufacturer for Details

    The recall record does not specify a return or replacement procedure; contact Hospira Inc. directly for further instructions.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Jun 17, 201412. FDA classified it Class I: Oct 1, 201423. Published in FDA’s Enforcement Report: Oct 8, 201434. FDA terminated the recall: Apr 3, 2017420142017
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled product?

The National Drug Code (NDC) is 0409-1560-29.

How many vials are being recalled?

A total of 40,730 single-dose vials are included in this recall.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0002-2015 (June 17, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0002-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA